Kelly Financial Services’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Kelly Financial Services’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-75	Closed	-$65	–	613
2019 Q4	$65	Hold	75	–	–	﹤0.01%	550
2019 Q3	$42	Buy	75 +25	+50%	+$13	﹤0.01%	544
2019 Q2	$26	Hold	50	–	–	﹤0.01%	497
2019 Q1	$23	Buy	+50	New	+$23	﹤0.01%	495

Kelly Financial Services's GCVRZ Position: Q1 2020 in Review

Kelly Financial Services sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 75 shares — an estimated $65 sold.

Kelly Financial Services first reported a position in GCVRZ in Q1 2019 and held it in 4 quarters. The position peaked at $65 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Kelly Financial Services reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Kelly Financial Services sold 75 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $65.
Kelly Financial Services first reported a position in Sanofi Contingent Value Rights in Q1 2019 and held it in 4 quarters.
Kelly Financial Services's Sanofi Contingent Value Rights position peaked at $65 in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Kelly Financial Services's 13F filing for Q1 2020, filed 17 Jul 2024.